#USA #Salt Lake City #Wegovy #GLP-1 #Shed

Shed Amplifies Weight-Loss Support with Wegovy® Pills

Shed, the innovative health and wellness platform, has taken a significant step forward in supporting weight management journeys. On January 14, 2026, the company announced the expansion of its GLP-1 weight-loss offerings with the introduction of Wegovy® pills through NovoCare. This initiative is designed to deliver accessible, clinically guided weight-loss solutions tailored to meet the unique needs of its members.

A New Approach to Weight Management

As the fight against obesity takes on increasing importance, Shed aims to provide sustainable and science-driven options for individuals looking to lose weight. The newly launched Wegovy® Pill Program adds to their existing suite of GLP-1 programs, giving members both oral and injectable formats to choose from based on their preference and health requirements.

Wegovy® Pill Details

• - Price: Starting at $149/month
• - Dosing Schedule: Daily oral dosing, beginning at 1.5 mg and gradually increasing to a maximum of 25 mg as clinically deemed appropriate.
• - Support: Ongoing provider oversight allows members to feel reassured throughout their weight-loss journey.

In addition to the oral option, Shed also provides a Wegovy® Injection Program for those who prefer the injectable route. This option includes:

• - Price: Starting at $199/month
• - Dosing: Initiates with 0.25 mg weekly for the first four weeks, with gradual increases based on the patient's response to treatment.
• - This ensures that the weight management strategy is as effective as possible, allowing for adjustments based on individual progress.

Comprehensive Member Support

Shed's broad approach to weight loss extends beyond just medication. The platform offers membership starting at $99/month, providing extensive access to GLP-1 programs and continuous support from healthcare providers. This membership ensures that participants not only receive medication but also enjoy meaningful guidance and tracking of their weight-loss journey.

CEO Morley Baker emphasized the importance of choice in weight-loss solutions, stating, "By offering both oral and injectable Wegovy® options, we're expanding access and choice for patients who want clinically proven weight-loss solutions without a one-size-fits-all approach." This flexibility enhances the user experience and promotes adherence to the program, ultimately leading to better results.

Beyond Wegovy®

Shed is not only introducing Wegovy® but is simultaneously maintaining its offerings of Zepbound®. This variety of evidence-based solutions provides members with multiple pathways to successful weight management under one cohesive care model. Members can choose the treatment that best aligns with their personal health goals, ensuring a tailored approach to their wellness journey.

Focus on Sustainability and Empowerment

The mission of Shed is to empower individuals to take charge of their health, and this latest initiative exemplifies that commitment. By merging modern weight-loss science with accessible care, Shed is redefining the landscape of weight management. Their comprehensive, patient-first approach emphasizes support, sustainability, and a pathway toward lasting change.

For those interested in embarking on their weight-loss journey with Shed's new Wegovy® offerings, more information can be found at tryshed.com.

Conclusion

With the expansion of Wegovy® pills along with ongoing support and multiple treatment options, Shed continues to position itself as a leader in health and wellness. This commitment to innovation and personalized care sets a new standard in the weight-loss industry, one that focuses not just on results but on overall wellbeing and sustained health.

• ---

For media inquiries, please contact:
Jamie Neider
Phone: 801-520-5785
Email: [email protected]
Shed - Helping people transform their health journey one step at a time.